M F Mosele, C B Westphalen, A Stenzinger, F Barlesi, A Bayle, I Bièche, J Bonastre, E Castro, R Dienstmann, A Krämer, A Czarnecka, F Meric-Bernstam, S Michiels, R Miller, N Normanno, J Reis-Filho, J Remon, M Robson, E Rouleau, A Scarpa, C Serrano, J Mateo, F André
BACKGROUND: Advancements in the field of precision medicine have prompted the European Society for Medical Oncology (ESMO) Precision Medicine Working Group to update the recommendations for the use of tumour next-generation sequencing (NGS) for patients with advanced cancers in routine practice. METHODS: The group discussed the clinical impact of tumour NGS in guiding treatment decision using the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) considering cost-effectiveness and accessibility...
May 27, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology